menopause and microdosing glp 1 for GLP-1s for Menopause-Related Weight Gain Menopause Hormone Therapy May Boost
Description
Whats really interesting is nobody did the research on liraglutide to look at pain
Basaglar carries approximately 25% hypoglycemia risk, while Ozempic has less than 1% risk
However, GLP-1 RAs may be considered to lower the CV risk in patients with T2D who have a high to very high risk of CVD, (class IIb, level C)
There were decreased risks that a person might experience chronic kidney disease and urinary tract infections
Studies on the anti-CVD cardiovascular effects of DPP-4 inhibitors are extensive
